Medical Devices & Home Care: WeOxy, based in Cambridge, launched the WeOxy Q5 portable oxygen concentrator, touting sub-2% failure rates, cold/high-altitude testing, and a “replacement-first” same-day swap policy. Healthcare Tech & Policy: Axxess is spotlighting its home-care data and compliance “intelligence ecosystem” ahead of a Boston summit on care-at-home financial sustainability. Biotech Financing: Agenus (Lexington) announced an oversubscribed private placement to fund neoadjuvant BOT+BAL for microsatellite-stable colon cancer, including its ROBBIN registrational trial. Pediatric Eye Disease: Sydnexis said the FDA plans an advisory committee meeting for SYD-101, its low-dose atropine therapy for pediatric progressive myopia. AI for Drug Discovery: Anthropic is pushing Claude Science for faster research, with Massachusetts’ Kendall Square ecosystem in the spotlight. Massachusetts Law & Psychedelics: Beacon Hill advanced a bill creating a five-year psychedelic-assisted therapy pilot for depression, anxiety, PTSD, and substance use disorder, with tightly limited provider eligibility. Security & Travel: A TSA funding lapse triggered uneven checkpoint staffing and major travel disruptions, with Georgia hit hardest. Life Sciences & AI Infrastructure: Modulate (Boston) ranked #1 on Hugging Face’s Open ASR leaderboard for transcription performance. Sanctions & Tech Exports: A Natick man convicted in federal court for conspiring to export electronics technology to Iran in violation of U.S. sanctions.